| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |